Radiotherapy & Oncology
Volume 94, Issue 3 , Pages 286-291 , March 2010

Multiinstitutional study on target volume delineation variation in breast radiotherapy in the presence of guidelines

Received 31 August 2009 ,Revised 30 November 2009 ,Accepted 23 January 2010.

References 

  1. Harsolia A, Kestin L, Grills I, et al. Intensity-modulated radiotherapy results in significant decrease in clinical toxicities compared with conventional wedge-based breast radiotherapy. Int J Radiat Oncol Biol Phys. 2007;68:1375–1380
  2. Hurkmans CW, Meijer GJ, van Vliet-Vroegindeweij C, et al. High-dose simultaneously integrated breast boost using intensity-modulated radiotherapy and inverse optimization. Int J Radiat Oncol Biol Phys. 2006;66:923–930
  3. van der Laan HP, Dolsma WV, Maduro JH, et al. Three-dimensional conformal simultaneously integrated boost technique for breast-conserving radiotherapy. Int J Radiat Oncol Biol Phys. 2007;68:1018–1023
  4. Vicini FA, Chen P, Wallace M, et al. Interim cosmetic results and toxicity using 3D conformal external beam radiotherapy to deliver accelerated partial breast irradiation in patients with early-stage breast cancer treated with breast-conserving therapy. Int J Radiat Oncol Biol Phys. 2007;69:1124–1130
  5. Offersen BV, Overgaard M, Kroman N, et al. Accelerated partial breast irradiation as part of breast conserving therapy of early breast carcinoma: a systematic review. Radiother Oncol. 2009;90:1–13
  6. Hurkmans CW, Borger JH, Pieters BR, et al. Variability in target volume delineation on CT scans of the breast. Int J Radiat Oncol Biol Phys. 2001;50:1366–1372
  7. Petersen RP, Truong PT, Kader HA, et al. Target volume delineation for partial breast radiotherapy planning: clinical characteristics associated with low interobserver concordance. Int J Radiat Oncol Biol Phys. 2007;69:41–48
  8. Struikmans H, Wárlám-Rodenhuis C, Stam T, et al. Interobserver variability of clinical target volume delineation of glandular breast tissue and of boost volume in tangential breast irradiation. Radiother Oncol. 2005;76:293–299
  9. Chen PY, Vicini FA. Partial breast irradiation. Patient selection, guidelines for treatment and current results. Frot Radiat Ther Oncol. 2007;40:253–271
  10. Polgar C, Fodor J, Major T, et al. Breast-conserving treatment with partial or whole breast irradiation for low-risk invasive breast carcinoma – 5-year result of a randomized trial. Int J Radiat Oncol Biol Phys. 2007;69:694–702
  11. Bartelink H, Horiot JC, Poortmans PM, et al. Impact of a higher radiation dose on local control and survival in breast-conserving therapy of early breast cancer: 10-year results of the randomized boost versus no boost EORTC 22881–10882 trial. J Clin Oncol. 2007;25:3259–3265
  12. Wong EK, Truong PT, Kader HA, et al. Consistency in seroma contouring for partial breast radiotherapy: impact of guidelines. Int J Radiat Oncol Biol Phys. 2006;66:372–376
  13. Landis DM, Weixiu Luo BS, Jun Song, et al. Variability among breast radiation oncologists in delineation of the postsurgical lumpectomy cavity. Int J Radiat Oncol Biol Phys. 2007;67:1299–1308
  14. Hurkmans C, Admiraal M, van der Sangen M, et al. Significance of breast boost volume changes during radiotherapy in relation to current clinical interobserver variations. Radiother Oncol. 2008;
  15. Pena PC, Kirova YM, Campana F, et al. Anatomical, clinical and radiological delineation of target volumes in breast cancer radiotherapy planning: individual variability, questions and answers. Brit J Radiol. 2009;82:595–599
  16. Li XA, Tai A, Arthur DW, et al. Variability of target and normal structure delineation for breast cancer radiotherapy: an rtog multi-institutional and multiobserver study. Int J Radiat Oncol Biol Phys. 2009;73:944–951
  17. Kirova YM, Fournier-Bidoz N, Servois V, et al. How to boost the breast tumor bed? A multidisciplinary approach in eight steps. Int J Radiat Oncol Biol Phys. 2008;72:494–500
  18. Poortmans PM, Collette L, Horiot JC, et al. Impact of the boost dose of 10 Gy versus 26 Gy in patients with early stage breast cancer after a microscopically incomplete lumpectomy: 10-year results of the randomised EORTC boost trial. Radiother Oncol. 2009;90:80–85
  19. Steenbakkers RJ, Duppen JC, Fitton I, et al. Observer variation in target volume delineation of lung cancer related to radiation oncologist-computer interaction: a ‘Big Brother’ evaluation. Radiother Oncol. 2005;77:182–190
  20. Yang T, Elkhuizen P, Minkema D, et al. Clinical factors associated with seroma volume reduction in breast-conserving therapy for early stage breast cancer, a multi-institutional analysis. Int J Radiat Oncol Biol Phys; doi:10.1016/j.ijrobp.2009.03.056.
  21. Weed DW, Yan D, Martinez AA, et al. The validity of surgical clips as a radiographic surrogate for the lumpectomy cavity in image-guided accelerated partial breast irradiation. Int J Radiat Oncol Biol Phys. 2004;60:484–492
  22. Giraud P, Elles S, Helfre S, et al. Conformal radiotherapy for lung cancer: different delineation of the gross tumor volume (GTV) by radiologists and radiation oncologists. Radiother Oncol. 2002;62:27–36
  23. Stroom J, Schlief A, Alderliesten T, et al. Using histopathology breast cancer data to reduce CTV margins at radiotherapy. Int J Radiat Oncol Biol Phys. 2009;74:898–905
  24. Vorerk H, Beckmann G, Bremer M, et al. The delineation of target volumes for radiotherapy of lung cancer patients. Radiother Oncol. 2009;91:455–460
  25. Benda RK, Mendenhall NP, Lind DS, et al. Breast-conserving therapy (BCT) for early-stage breast cancer. J Surg Oncol. 2004;85:14–27
  26. Jalali R, Singh S, Budrukkar A, et al. Techniques of tumour bed boost irradiation in breast conserving therapy: current evidence and suggested guidelines. Acta Oncol. 2007;46:879–892

PII: S0167-8140(10)00060-5

doi: 10.1016/j.radonc.2010.01.009

Radiotherapy & Oncology
Volume 94, Issue 3 , Pages 286-291 , March 2010

Article Tools

* Image Usage & Resolution